|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/197 | (2013.01) |
| A61K 31/5025 | (2006.01) | ||
| A61K 31/522 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| Y10S 514/866 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61K 31/155 | (2013.01) | ||
| A61P 9/06 | (2006.01) | ||
| A61K 31/522 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61K 31/5025 | (2013.01) | ||
| A61P 9/14 | (2006.01) | ||
| A61K 31/52 | (2013.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/38 | (2018.01) | ||
| A61P 5/48 | (2018.01) | ||
| A61P 5/50 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/04 | (2018.01) | ||
| A61P 9/06 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61P 9/14 | (2018.01) |
| (11) | Number of the document | 2397142 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11179908.6 |
| Date of filing the European patent application | 2007-05-03 | |
| (97) | Date of publication of the European application | 2011-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 06009203 | 2006-05-04 | EP |
| (72) |
Dugi, Klaus , DE
Himmelsbach, Frank , DE
Mark, Michael , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
Boehringer Ingelheim Pharma GmbH & Co. KG , Binger Strasse 173, 55216 Ingelheim, DE |
| (54) | Verwendungen von DPP IV Inhibitoren |
| Use of DPP IV inhibitors |